Nisha Narayan
banner
nishanarayan.bsky.social
Nisha Narayan
@nishanarayan.bsky.social
Blood Cancer UK Early Career Advancement Fellow @scicambridge.bsky.social | PhD @wehi-research.bsky.social 🇦🇺🏴󠁧󠁢󠁥󠁮󠁧󠁿

https://www.linkedin.com/in/nisha-narayan
Pinned
Getting ready for another EHA Congress #EHA2025. Looking forward to seeing friends and colleagues in Milan! Drop me a message if you’ll be there too!
Reposted by Nisha Narayan
PhD opportunity (open to UK-Students only):

Interested in PhD project where you investigate environmental factors driving lung cancer inequalities?

The project allows you to learn computational and lab experimental approaches

Deadline: 30th June

Please share!
www.findaphd.com/phds/project...
CRUK Scotland Centre - Investigating Asbestos exposure and other environmental factors underpinning Lung cancer inequalities in the Scottish population at University of Glasgow on FindAPhD.com
PhD Project - CRUK Scotland Centre - Investigating Asbestos exposure and other environmental factors underpinning Lung cancer inequalities in the Scottish population at University of Glasgow, listed o...
www.findaphd.com
June 16, 2025 at 1:22 PM
Getting ready for another EHA Congress #EHA2025. Looking forward to seeing friends and colleagues in Milan! Drop me a message if you’ll be there too!
June 10, 2025 at 11:25 AM
Reposted by Nisha Narayan
We are delighted to announce further funding for ground-breaking leukaemia research through our 2025 Project Grants!

Applications will open on 2nd June 2025. Please share amongst your research networks! 🔬

Find out more and apply 👉 leukaemiauk.org.uk/research-and...
May 15, 2025 at 9:31 AM
Reposted by Nisha Narayan
Passionate about structural biology and #biochemistry? Join David Haselbach’s group through the Vienna BioCenter #PhD Program!

⏳ Deadline: April 15 🚨, apply now: training.vbc.ac.at/phd-program/

📽️Watch David's 'Scientist Snapshot': youtube.com/watch?v=DXTO...

@haselbachlab.bsky.social
April 7, 2025 at 9:13 AM
Reposted by Nisha Narayan
Celldetective: an AI-enhanced image analysis tool for unravelling dynamic cell interactions.
buff.ly/D3mcHd6
March 21, 2025 at 11:01 AM
Reposted by Nisha Narayan
"But what did he publish since?"
March 17, 2025 at 9:20 AM
Reposted by Nisha Narayan
SiRCle (Signature Regulatory Clustering) model integration reveals mechanisms of phenotype regulation in renal cancer

Please check this work from Christina Schmidt and Ariane Mora, in collaboration with the Boden lab. We explore the regulatory network of ccRCC. 🧪

link.springer.com/article/10.1...
SiRCle (Signature Regulatory Clustering) model integration reveals mechanisms of phenotype regulation in renal cancer - Genome Medicine
Background Clear cell renal cell carcinoma (ccRCC) tumours develop and progress via complex remodelling of the kidney epigenome, transcriptome, proteome and metabolome. Given the subsequent tumour and...
link.springer.com
December 4, 2024 at 10:17 AM
Reposted by Nisha Narayan
First post on BSky and I'm going to use it to promote the outstanding line up of faculty that we've managed to put together for #ISEH2025 in Kumamoto, Japan (with more to come). Save the date: lots of space reserved in the program for you to present your exciting science! Link below.
🚨 Save the Date!🚨 ISEH is heading to Kumamoto, Japan for #ISEH2025. Check out our confirmed speakers so far and mark your calendars for a great program you won't want to miss ➡️ iseh.org/iseh2025
November 27, 2024 at 7:45 AM
Reposted by Nisha Narayan
Glucose limitation protects cancer cells from apoptosis induced by pyrimidine restriction and replication inhibition 🧪

Congrats @richpossemato.bsky.social & team for the very cool work!

www.nature.com/articles/s42...
Glucose limitation protects cancer cells from apoptosis induced by pyrimidine restriction and replication inhibition - Nature Metabolism
Nam et al. show that limited glucose availability similar to the tumour microenvironment confers resistance against chemotherapeutic drugs that target DNA synthesis.
www.nature.com
November 27, 2024 at 5:22 AM
Reposted by Nisha Narayan
Autophagy inhibition induces AML cell death and enhances the efficacy of chemotherapy under hypoxia https://www.biorxiv.org/content/10.1101/2024.11.24.625107v1
Autophagy inhibition induces AML cell death and enhances the efficacy of chemotherapy under hypoxia https://www.biorxiv.org/content/10.1101/2024.11.24.625107v1
Outcomes of relapsed/refractory acute myeloid leukemia (AML) are poor, and strategies to improve out
www.biorxiv.org
November 26, 2024 at 12:47 PM
Reposted by Nisha Narayan
Closing the scissor-shaped curve: Strategies to promote gender equality in academia. #Cell

Read more
www.cell.com/cell/abstrac...
November 25, 2024 at 1:01 PM